Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis
- Authors: Kalyuzhin OV1, Ponezheva Z.B2, Semenova IV2, Khokhlova ON2, Serebrovskaya LV2, Guseva TS3, Parshina OV3, Maleev VV2
-
Affiliations:
- ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России
- ФБУН ЦНИИ эпидемиологии Роспотребнадзора
- ФГБУ ФНИЦЭМ им. Н.Ф. Гамалеи Минздрава России
- Issue: Vol 89, No 11 (2017)
- Pages: 14-20
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32281
- DOI: https://doi.org/10.17116/terarkh2017891114-20
- ID: 32281
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O V Kalyuzhin
ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
Zh B Ponezheva
ФБУН ЦНИИ эпидемиологии РоспотребнадзораМосква, Россия
I V Semenova
ФБУН ЦНИИ эпидемиологии РоспотребнадзораМосква, Россия
O N Khokhlova
ФБУН ЦНИИ эпидемиологии РоспотребнадзораМосква, Россия
L V Serebrovskaya
ФБУН ЦНИИ эпидемиологии РоспотребнадзораМосква, Россия
T S Guseva
ФГБУ ФНИЦЭМ им. Н.Ф. Гамалеи Минздрава РоссииМосква, Россия
O V Parshina
ФГБУ ФНИЦЭМ им. Н.Ф. Гамалеи Минздрава РоссииМосква, Россия
V V Maleev
ФБУН ЦНИИ эпидемиологии РоспотребнадзораМосква, Россия
References
- Yang Y, Zhou Y, Hou J, Bai C, Li Z, Fan J, Ng IO, Zhou W, Sun H, Dong Q, Lee JM, Lo CM, Man K, Yang Y, Li N, Ding G, Yu Y, Cao X. Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma. Hepatology. 2017. https://doi.org/10.1002/hep.29156
- Boisvert M, Shoukry NH. Type III interferons in hepatitis C virus infection. Front Immunol. 2016;7:628. https://doi.org/10.3389/fimmu.2016.00628
- Lin Z, Zhang J, Ma X, Yang S, Tian N, Lin X, Zhou S, Liu L, Gao Y. The Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-Analysis. Hepat Mon. 2016;16(7): e37534. https://doi.org/10.5812/hepatmon.37534
- Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J; German Anti-D Study Group. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology. 2010;139:1586-1592. https://doi.org/1592e1581.10.1053/j.gastro.2010.07.005
- Chen CL, Huang JY, Wang CH, Tahara SM, Zhou L, Kondo Y, Schechter J, Su L, Lai MM, Wakita T, Cosset FL, Jung JU, Machida K. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2. Nat Commun. 2017;8:13882. https://doi.org/10.1038/ncomms13882
- Sinha M, Rao CR, Premalata CS, Shafiulla M, Lakshmaiah KC, Jacob LA, Babu GK, Viveka BK, Appaji L, Subramanyam JR. Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses. Indian J Med Paediatr Oncol. 2016; 37(3):146-151. https://doi.org/10.4103/0971-5851.190353
- Kuo M-T, Hu T-H, Lu S-N, Hung CH, Wang J-H, Chen C-H, Chiu Y-C, Lee C-M. Neutrophil-to-lymphocyte ratio as a predictor of response to peginterferon plus ribavirin therapy for chronic hepatitis C. Disease Markers. 2014;2014:462958. https://doi.org/10.1155/2014/462958
- Gomez D, Farid S, Malik H Z, Young AL, Toogood GJ, Lodge JPA, Prasad KR. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World Journal of Surgery. 2008;32(8):1757-1762. https://doi.org/10.1007/s00268-008-9552-6
- Chen T-M, Lin C-C, Huang P-T, Wen C-F. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. Journal of Gastroenterology and Hepatology. 2012;27(3):553-561. https://doi.org/10.1111/j.1440-1746.2011.06910.x
- Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Akarca US. Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci. 2007;52(6):1535-1539. https://doi.org/10.1007/s10620-006-9144-y
- Al-Qahtani A, Al-Anazi M, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalaf Nisreen, Viswan N, Al-Ahdal MN. Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection. Journal of Immunology Research. 2015;2015:768470. https://doi.org/10.1155/2015/768470
- Depla M, Pelletier S, Bedard N, Brunaud C, Bruneau J, Shoukry NH. IFN-lambda3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection. Immun Inflamm Dis. 2016;4:376-388. https://doi.org/10.1002/iid3.122
- Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS One. 2012;7:e44915. https://doi.org/10.1371/journal.pone.0044915
- Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399-401. https://doi.org/10.1038/nature08309
- Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, et al. Interferon-lambda serum levels in hepatitis C. J Hepatol. 2011;54:859-865. https://doi.org/10.1016/j.jhep.2010.08.020
- Torres C, Brahm J, Venegas M. Lambda interferon serum levels in patients with chronic hepatitis C virus infection according to their response to therapy with pegylated interferon and ribavirin. J Interferon Cytokine Res. 2014;34:106-110. https://doi.org/10.1089/jir.2013.0005
- Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O’Shea JJ, Biron CA. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 2002;297:2063-2066. https://doi.org/10.1126/science.1074900
- Pien GC, Nguyen KB, Malmgaard L, Satoskar AR, Biron CA. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J Immunol. 2002;169:5827-5837. https://doi.org/10.4049/jimmunol.169.10.5827
- Донцов Д.В., Романова Е.Б., Амбалов Ю.М. Метод альтернативного анализа Вальда как способ прогноза прогрессирования заболевания у больных хроническим гепатитом С. Кубанский научный медицинский вестник. 2011;4(127):69-71. Ссылка активна на: 21.05.2017. Доступно по: http://cyberleninka.ru/article/n/metod-alternativnogo-analiza-valda-kak-sposob-prognoza-progressirovaniya-zabolevaniya-u-bolnyh-hronicheskim-gepatitom-s
- Weng HL, Wang BE, Jia JD, Wu WF, Xian JZ, Mertens PR, Cai WM, Dooley S. Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin Gastroenterol Hepatol. 2005;3(8):819-828. https://doi.org/10.1016/s1542-3565(05)00404-0
- Muir AJ, Sylvestre PB, Rockey DC. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. J Viral Hepat. 2006;13(5):322-328. https://doi.org/10.1111/j.1365-2893.2005.00689.x
- Knight B, Lim R, Yeoh GC, Olynyk JK. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. J Hepatol. 2007;47(6):826-833. https://doi.org/10.1016/j.jhep.2007.06.022
![](/img/style/loading.gif)